NovAccess Global Inc. (OTCMKTS:XSNX – Get Rating) saw a significant decline in short interest in February. As of February 28th, there was short interest totalling 3,600 shares, a decline of 52.6% from the February 13th total of 7,600 shares. Based on an average trading volume of 6,200 shares, the short-interest ratio is currently 0.6 days.

NovAccess Global Price Performance

XSNX stock opened at $0.18 on Friday. The firm has a 50 day simple moving average of $0.19 and a two-hundred day simple moving average of $0.20. NovAccess Global has a one year low of $0.10 and a one year high of $0.60.

NovAccess Global Company Profile

(Get Rating)

NovAccess Global, Inc is a biopharmaceutical company, which engages in the provision of diagnostics, therapeutics in cancer, and neurological diseases and the development of immunotherapies to treat brain tumor patients. The company was founded on February 25, 1997 and is headquartered in Cuyahoga County, OH.

Featured Articles

• Get a free copy of the StockNews.com research report on NovAccess Global (XSNX)
• Just the Catalyst NIO Investors Needed
• FuelCell Energy Gains Traction, Shares Surge
• Solo Brands May Remind Investors Why Cash is King
• Someone Is Buying The Dip In MongoDB
• Etsy Stock: Crafty Bargain or Piece of Junk?

Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.